🦊/Investors

BioTrack Capital

Private equity

Grand Cayman · Seed–Late Stage · 6 people tracked

Also known as BIOTRACK FUND II GP LIMITED

Find your way into BioTrack Capital

559 people in our graph share verified history with the BioTrack Capital team — schools, employers, funds. One of them is your warm intro.

Damir Becirovicunlockedknows Jiacong Guo · together at University of Southern California (overlapped)
×4knows the team · via University of Southern California
×3knows the team · via Fudan University
knows the team · via China Europe International Business School (CEIBS)
×2knows the team · via Tongji University
knows the team · via Hill House
Fox Verdict
Sign up to see your fit

Investment thesis

BioTrack Capital is a venture capital firm founded in 2017 that invests in early-stage companies in biotechnology, medical devices, and healthcare-related sectors including artificial intelligence, digital health, and consumer health. The firm's investment team has backgrounds in research and development, clinical operations, consulting, and venture capital.

Source: firm website, verified Sep 15, 2026.

Stage
Seed–Late Stage
HQ
Grand Cayman, CN
Instruments
Equity
Founded
2017
AUM
$1B
Tracked investments
2

Team · 6 people

from public directories
Penghui Chen· General Partner
Zhongji Zhi· General Partner
Jingfei Zhang· Principalin
Jiacong Guo· Vice Presidentin

What they invest in

from 2 of 2 portfolio companies

Biotech ×2Deep Tech ×2AI & Machine Learning ×1Healthtech ×1

HQs:United States×1

Investments · 2 tracked

founders shown can be your intro path
EdiGeneedigene.comApr 2021 · $62M

EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.

BiotechDeep TechHealthtech

Co-investorsLAVLilly Asia VenturesWI Harper Group3H Health InvestmentAlwin CapitalIDG Capital+2 more

Rapafusynrapafusyn.comin

Rapafusyn develops molecular glue therapeutics using its RapaGlue platform of non-degrading macrocyclic compounds designed to modulate hard-to-drug intracellular and transmembrane protein targets.

AI & Machine LearningBiotechDeep TechBaltimore, US

Jun O. Liu(Founder)

Co-investors3E Bioventures Capital

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does BioTrack Capital invest at?
BioTrack Capital invests at the Seed, Series A, Series B, Series C, Late Stage stages.
What sectors does BioTrack Capital focus on?
BioTrack Capital focuses on Biotech, Healthtech, Medical Devices.
Where is BioTrack Capital located?
BioTrack Capital is headquartered in Grand Cayman, CN.

Similar investors

Featured in lists